Treatments for neuroleptic malignant syndrome.
D000328:Adult; D000547:Amantadine / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001971:Bromocriptine / Q000627:therapeutic use; D002389:Catatonia / Q000139:chemically induced; D004565:Electroconvulsive Therapy; D005334:Fever / Q000139:chemically induced / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008297:Male
D014150:Antipsychotic Agents; D001971:Bromocriptine; D007980:Levodopa; D000547:Amantadine